课题基金 / 基金详情

Structure/function analysis of the Ral/RLIP signalling pathway as a therapeutic target

Structure/function analysis of the Ral/RLIP signalling pathway as a therapeutic target
作为治疗靶点的 Ral/RLIP 信号通路的结构/功能分析
批准号:
G0700057/1
负责人:
Helen Mott
金额:
$79.14万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2007
资助国家:
英国
项目状态:
已结题
起止时间:
2007 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our work addresses the relationship between structure and function in proteins involved in signalling within the cell. These proteins control many signal transmission pathways that become deregulated in cancer and other diseases. The proteins that we study are important in the progression of a cell from being normal to being cancerous, a process that requires a combination of increased growth and resistance to normal cell death. The protein that we are proposing to concentrate on here, RLIP-76, is involved in many processes. It is important for stress responses and also for bringing molecules into the cell, a process that is strictly controlled. Both of these pathways are important in cancer progression. RLIP-76 can also act as a pump that removes chemotherapy drugs from cells, making them less effective. If we can understand more about how RLIP-76 is activated in all of these different processes, we might be able to find ways to inhibit it; so one of the things we will look at is the mechanism of RLIP-76 activation. One of the most important things that proteins do in cells is to bind to other proteins. Although we know which proteins RLIP-76 binds to, we do not know how it binds to them. So one of the other major aims of our research is to understand how RLIP-76 binds to these other proteins. We do this by working out what the complex of RLIP-76 and its partner looks like in three dimenensions. This is crucial, because if we know how proteins bind to each other and which particular regions of the proteins are important for the interaction, it will be possible to design drugs that either prevent or enhance this binding,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
  • 批准号:
    82371651
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵栋
  • 依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
  • 批准号:
    82370798
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王晓
  • 依托单位:
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨成
  • 依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
  • 批准号:
    82370851
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    包玉倩
  • 依托单位: